Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Resources
Science Hub
Press releases
News
Events
Media kit
Services
Process Development
Analytics
Drug Substance Manufacturing
Contact
Contact form
Contact for investors
Contact for media
Careers
Science News
Resources
Mabion
Bioanalytics at Mabion supporting Clinical Trials with Precise Data
Bioanalytics
,
Clinical trials
,
Mabion
Preparing for Regulatory Audits at Mabion with Reliable Quality Systems
Biologics
,
EMA
,
FDA
,
GMP
,
Mabion
,
Regulatory
Meeting Global Regulatory Standards in Biologic Drug Manufacturing Projects
Biologics
,
EMA
,
FDA
,
GMP
,
Mabion
,
Manufacturing
,
Regulatory
Poster
Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency
Biologics
,
Drug development
,
Mabion
,
Manufacturing
Co-Development Partnership Models in Biologics Programs
Biologics
,
Drug development
,
Mabion
,
Partnership
From Research to Release: Mapping Mabion’s Full Analytical Lifecycle for Monoclonal Antibodies
Analytics
,
Mabion
,
Monoclonal antibody
The New Era of Biosimilar Development: Seizing the Opportunity Under EMA’s Streamlined Guidelines
Biosimilars
,
Clinical trials
,
Drug development
,
EMA
,
FDA
,
Mabion
,
Regulatory
Does Your CDMO Have An Analytical Edge?
Analytics
,
Biosimilars
,
Mabion
Quality as the Basis for CDMO Partnership Success
GMP
,
Mabion
1
2
Next